skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines lebrikizumabQuestion & answer

lebrikizumab · Medicine question

Which cytokine does lebrikizumab target to inhibit its signalling?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Lebrikizumab targets interleukin-13 (IL-13), binding to it with high affinity and selectively inhibiting its signalling.

Sources for this answer

Ebglyss 250 mg solution for injection in pre-filled syringeAlmirall Limited · emc · SmPC §5.1 Pharmacodynamic properties · Version 5Document updated 28 January 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about lebrikizumab

Does lebrikizumab affect the ability to drive or use machines?How much polysorbate 20 does each Ebglyss (lebrikizumab) 250 mg pre-filled syringe contain?Is it known whether lebrikizumab passes into human breast milk?What injection-site reactions have been reported with lebrikizumab in patients with atopic dermatitis?What is the recommendation regarding lebrikizumab use during pregnancy?Which body sites can be used for lebrikizumab injections?

lebrikizumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the lebrikizumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX